Trial intelligence / Profile preview

ID vs IM H5N1 Influenza Vaccine in Healthy Adults

NCT00439335Phase 2Completed

Sponsor
National Institute of Allergy and Infectious Diseases
Start
Mar 2007
Primary completion
Feb 2008
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of inactivated influenza a vaccine A/H5N1 in Influenza A H5N1 infection (H5N1), sponsored by National Institute of Allergy and Infectious Diseases. Started Mar 2007; status: completed.

02

Drugs

inactivated influenza a vaccine A/H5N1
03

Conditions

Influenza A H5N1 infection (H5N1)

Beyond the preview

Go deeper on NCT00439335.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00439335.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call